Target Name: LOC105370214
NCBI ID: G105370214
Review Report on LOC105370214 Target / Biomarker Content of Review Report on LOC105370214 Target / Biomarker
LOC105370214
Other Name(s): LOC105370214 variant X1 | uncharacterized LOC105370214 | Uncharacterized LOC105370214, transcript variant X1

LOC105370214: A Potential Drug Target for Alzheimer's and Other neurological Disorders

LOC105370214 (LOC105370214 variant X1) is a protein that is expressed in the human brain and is involved in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is of particular interest as a potential drug target or biomarker due to its unique structure and the diseases it is associated with.

The LOC105370214 protein is a member of the insulin secretion receptor (ISR) family, which is a family of transmembrane proteins that are involved in intracellular signaling. The ISR family plays a crucial role in regulating insulin signaling, which is a critical process for maintaining cellular homeostasis and promoting growth and development.

LOC105370214 is unique in that it is a single-spaced transmembrane protein that contains multiple domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in cell adhesion and signaling, while the transmembrane domain is involved in the regulation of ion channels and the formation of homotypic interactions. The intracellular domain is involved in protein-protein interactions and the regulation of intracellular signaling pathways.

The LOC105370214 protein is expressed in the brain and is involved in the development and progression of various neurological disorders, including Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder that is characterized by the accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain. These tangles and plaques are thought to contribute to the neurodegeneration that occurs in Alzheimer's disease, and targeting LOC105370214 may be a potential strategy for treating the disease.

In addition to its association with Alzheimer's disease, LOC105370214 is also thought to be involved in other neurological disorders, including Parkinson's disease and multiple sclerosis. These disorders are characterized by the accumulation of neurofibrillary tangles and other aberrant proteins in the brain, and targeting LOC105370214 may be a potential strategy for treating these disorders as well.

The unique structure of LOC105370214 may also make it an attractive drug target or biomarker. The protein is involved in multiple signaling pathways, and targeting its various domains may be effective in inhibiting its activity and reducing the formation of neurofibrillary tangles and beta-amyloid plaques. This could have potential implications for the treatment of various neurological disorders.

In conclusion, LOC105370214 is a protein that is expressed in the human brain and is involved in the development and progression of various neurological disorders, including Alzheimer's disease. Its unique structure and the diseases it is associated with make it an attractive potential drug target or biomarker. Further research is needed to fully understand the role of LOC105370214 in neurological disorders and to develop effective treatments.

Protein Name: Uncharacterized LOC105370214

The "LOC105370214 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370214 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275